The New York Eye and Ear Infirmary Revenue and Competitors

Location

N/A

Total Funding

Health

Industry

Estimated Revenue & Valuation

  • The New York Eye and Ear Infirmary's estimated annual revenue is currently $220.4M per year.(i)
  • The New York Eye and Ear Infirmary's estimated revenue per employee is $337,500

Employee Data

  • The New York Eye and Ear Infirmary has 653 Employees.(i)
  • The New York Eye and Ear Infirmary grew their employee count by 4% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.1M3318%N/AN/A
#2
$16.8M69-1%N/AN/A
#3
$394.6M1044-7%N/AN/A
#4
$0.2M8-27%N/AN/A
#5
$4M21-16%N/AN/A
#6
$5.1M27-18%N/AN/A
#7
$6.7M31-9%N/AN/A
#8
$8.4M3911%N/AN/A
#9
$7.8M363%N/AN/A
#10
$8.2M38-3%N/AN/A
Add Company

The New York Eye and Ear Infirmary, the oldest specialty hospital in the Western Hemisphere, is the primary teaching hospital for the New York Medical College. It has approximately 142,000 outpatient visits annually and over 20,000 surgical procedures per year. It has one of the nations most extensive eye, ear, nose and throat clinics.

keywords:N/A

N/A

Total Funding

653

Number of Employees

$220.4M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

The New York Eye and Ear Infirmary News

2022-04-17 - 35-Year-Old's Canker Sore Was Actually Stage 4 Tongue Cancer

... local ear, nose and throat doctors and made an appointment to see Dr. Diana Kirke, an otolaryngologist at New York Eye and Ear Infirmary...

2022-04-06 - Newly Designed Children's Emergency Department Opens at ...

New York Eye and Ear Infirmary of Mount Sinai is ranked No. 12 in Ophthalmology. Mount Sinai Kravis Children's Hospital is ranked in U.S....

2022-03-30 - Mount Sinai Health System Launches Mobile Prostate Cancer ...

New York Eye and Ear Infirmary of Mount Sinai is ranked No. 12 in Ophthalmology. Mount Sinai Kravis Children's Hospital is ranked in U.S....

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$204.9M65337%N/A
#2
$118.4M65320%N/A
#3
$61.5M654N/AN/A
#4
$171.9M65528%N/A
#5
$204.7M6556%N/A